What Are the Implications of the Recent Elimination of the Medicaid Prescription Drug Rebate Cap?

KFF recently released a policy watch titled “What Are the Implications of the Recent Elimination of the Medicaid Prescription Drug Rebate Cap?” As of January 1, 2024, the American Rescue Plan Act (ARPA) lifted the cap on the total amount of rebates that Medicaid could collect from manufacturers who raise drug prices substantially over time. Anticipating the implementation of this policy, drug manufacturers have made various changes allowing them to avoid increased rebates resulting from the lifting of the cap. Recent changes that have garnered attention include price cuts for insulin, used to treat diabetes, and the discontinuation of Flovent, a frequently used asthma inhaler....